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INTRODUCTION
                Pterygia, the wing shaped fleshy growth on corneal limbus 
have been known to physicians for thousands of years. Sushrutha  (Circa 
1000  BC)  has  recorded  pterygium  removal.  The  term  pterygium 
meaning  wing  (pteryx –  wing )  was  introduced  by  Walton in  1875. 
Despite  being recognised for  many  years,  very  little  is  known about 
about its pathogenesis.
                It has been accepted for sometime now that environmental  
factors are responsible for development of pterygium. More recently, it 
has been clear that UV light exposure is most important environmental 
influence.  Majority  of  pterygia  occurring  on  nasal  limbus  has  been 
attributed to the fact that reflected sunlight is preferentially focused at 
this point. But exact way in which UV light interacts with limbus and 
cornea to produce a pterygium is unknown.
                Genetic factors also are important. In particular environments 
some racial groups are more affected than others and there is tendency 
for pterygia to occur in families.
                Histopathology is nonspecific and does little to suggest an  
underlying cause. The usual picture is that of hyaline degeneration and 
low grade inflammatory reaction.
Surgical  excision  remains  principle  mode  of  treatment  for 
pterygium.  Various  techniques  have  been  tried  like  simple  excision, 
Bare  sclera  method,  Transplantation  of  head  of  pterygium,  mucous 
membrane or conjunctival graft or flap to cover bare sclera and Lamellar 
keratoplasty. Unfortunately none of these techniques are successful in 
all  cases and recurrence still remains most  enigmatic complication of 
pterygium excision.
Many approaches have evolved as an alternative to or adjunctive 
to surgical excision. Ionising radiation, heat, laser, antimetabolites etc. 
have been advocated as adjuncts to surgery. Many of these techniques 
have either been unsuccessful or associated with serious complications.
              In recent years, focus has shifted to use of planned surgical 
repair  with  a  flap  of  normal  conjunctiva  or  limbus  in  treatment  of 
pterygia. Improved results with this form of repair have encouraged the 
implication  of  limbal  stem  cells  in  aetiology  and  pathogenesis  of 
pterygia. These cells are responsible for corneal epithelial regeneration 
and transdifferentiation and serve as a barrier to prevent conjunctival 
ingrowth onto cornea.
              Localised damage to limbal stem cells at nasal or temporal 
limbus  can  be  caused  by   UV light  or  other  environmental  factors. 
Damaged  limbal  stem  cells  lose  their  barrier  function  &  allow 
conjunctival ingrowth. Furthermore they may release vasoproliferative 
substance that encourage pterygium formation.
           According to this new concept , pterygium develops due to focal 
deficiency,  absence  or  aplasia  of  limbal  stem  cells  &  therefore 
transplantation of limbal stem cells is considered as the most convincing 
approach for treatment of pterygia.
HISTORICAL REVIEW
                 Pterygium has been recognised from ancient times dating 
back to 1000BC. The first  person to record it  is  Susruta.  Since then 
Celsus  (29AD),  Paul  (600AD),  Avicenna  (1037AD)  and  others  have 
described it in detail. This simple appearing, easily removable lesion is 
sometimes a challenging one because of high rate of recurrence.
                  It appears that for about 30 centuries, man has tried to  
conquer pterygium. They tried various forms of collyrium of lead, zinc, 
copper, iron, bile, women’s milk, vinegar, cuttlefish bone, lead acetate, 
silver  nitrate  etc  as  medical  treatment.  Sushruta  has  recorded  a 
pterygium removal.
                “ With the patient in recumbent position on an operating table, 
the pterygium is loosened & disturbed by sprinkling powdered salt into 
the eye ; with the patient looking laterally, a sharp hook is used to secure 
the growth at its loosened upturned part…the pterygium is got ridden by 
scratching it with a sharp round topped instrument. Any remnant of the 
pterygium should be removed with a scarifying instrument to prevent 
recurrence.
               Sushruta’s technique suggests that even in ancient times, the 
problems of pterygium management were recognised. Apparently, care 
was taken to remove any tissue remnants in the hope that there would be 
no recurrence.
             For a long time, the pterygium was considered to be a type of  
pannus from which it was differentiated by Chelsius (1839). Von arlt 
(1854)  proposed  an  inflammatory  basis  for  occurrence  of  pannus  & 
suggested that it is a result of corneal ulcer.
             Hasner Edlem Von Artha & Schreiter suggested a neoplastic 
aetiology  (1847).  Later  it  was  thought  to  be  due  to  disturbances  of 
venous circulation in anterior ciliary veins (Winther, Von Hippel /1866) 
or  due  to  disturbances  of  extraocular  muscles  (Theobald  1887)  or 
eyelids (Bond 1889).
             An association with the ultraviolet rays in solar radiation has 
been found the most significant environmental factor (Cameron 1964).
             Attempts at local medication such as by application of solid 
choline chloride was evaluated by Beard and Dimitry(1945). Anastasi 
(1953)  had  treated  the  condition  with  topical  use  of  steroids  or 
subconjunctival  injection  of  hyaluronidase.  According  to  Helgers 
(1960), it stimulates rather than inhibit growth.
             Scarpa (1802) was the first to perform a kind of bare sclera 
excision. Excision with simple closure of the wound was advocated by 
Von Arlt (1850-74). Terrien brought pterygium growth upward to upper 
fornix.  Knapp  (1868)  bisected  the  growth  and  pulled  upper  half 
superiorly and lower half inferiorly. A lamellar corneal graft applied to 
denuded area of cornea after excision was suggested by Magitot (1916).
                Bare sclera method in which after excision, a small area of 
sclera  in  relation  to  affected  area  of  cornea  is  not  covered  by 
conjunctiva,  but  is  thoroughly denuded of  subconjunctival  tissue was 
described by D’ombrain (1948).
               Beta radiation (King 1950), X-rays, Argon laser (Caldwell 
1985)  have  been  tried  as  adjuvants  to  surgical  excision  to  prevent 
recurrence.  Topical  instillation  of  antimitotics  was  tried  by  Mecham 
(1962).  In  1963  Kunimoto  & Mori  first  used  Mitomycin  C  to  treat 
pterygia.
            Free tissue grafts to cover bare sclera was introduced by Klien 
(1876)  by  using  mucous  membrane  grafts.  Hobby  (1888)  mobilised 
adjacent conjunctiva. As early as 1926, Elschnig as well as Spaeth used 
free  conjunctival  grafts  in  treating  pterygia  (  Duke  Elder).  Recently 
Barraquer (1980), Dowlut and Laflamme (1981), Vastine and associates 
(1982)  as  well  as  others  have  repopularised  the  use  of  conjunctival 
autograft  transplantation  in  the  management  of  pterygia  with  high 
success rate.
               Recently the inclusion of limbal tissue in conjunctival graft has 
gained  popularity.  Srinivas  et  al  (IJO  1998)  have  reported  the 
importance of including the limbal tissue in the conjunctival graft for 
prevention of recurrence.
EPIDEMIOLOGY
                 Pterygium has worldwide distribution. More common in 
warm, dry climates.  It has got a equatorial prevalence of 22% and less 
than 2% in latitudes above 40deg.
                 A large case control study in Australia identified number of 
risk factors for development. 
- 44 fold greater relative risk of pterygium development for persons 
living in tropics (< 30deg latitude).
- 11 fold for working in a sandy, outdoor environment, 9 fold for 
patients without a history of wearing spectacles or sunglasses.
   - 2 fold for those who never wear a hat.
                 In Northern climates, it is exclusively confined to fishermen 
and rural workers. Taylor & colleagues found a statistically significant 
association  between  UV light  exposure  (both  UV-A & UV-B )  and 
development  of  pterygium  in  a  larger  group  of  Chesaparke  Bay 
fishermen.  From these  studies,  relationship  between  UV radiation  & 
pterygium formation is obviously strong.
                  UV exposure may not be the only factor. Punjabi workers 
exposed  to  dusty,  indoor  environment  had  higher  prevalence  of 
pterygium than who experienced higher level of outdoor UV radiation.
                  One study among welders exposed to higher levels of UV 
light  show  direct  relationship  between  length  of  employment   & 
incidence of  pterygium . In contrast, more recent study found pterygium 
to be rare (<0.5%)  among welders.
                   Local drying of cornea and conjunctiva in interpalpabral  
fissure from tear film abnormality can lead to new fibroblastic growth 
according to one theory. Increased incidence in windy, dry climates is 
consistent with this hypothesis.
                  Patients < 15yrs of age rarely acquire pterygium. Although 
prevalence increases with age, highest incidence occurs between ages 20 
and  40.  Recurrence  more  frequent  in  young  adults  than  older 
individuals.
                   Pedigree analysis has demonstrated families with dominant  
mode of inheritance although most cases appear to be sporadic.
AGE AND SEX DISTRIBUTION
                   Men working outdoors are more affected. Males and 
females  who  worked  indoors  were  equally  affected.  On  the  whole, 
pterygium  occurs  twice  as  often  in  men  as  in  women.  While  the 
prevalence is highest in the elderly, development of new cases is highest 
between ages of 20 and 40 years.
CLASSIFICATION
                   Pterygium is essentially a triangular encroachment of the 
bulbar  conjunctiva  on  the  cornea.  It  is  a  degenerative  condition  of 
subconjunctival tissue.
                   A true pterygium and pseudopterygium  were differentiated  
by Winther ( 1956 ).
- A true pterygium is a degenerative and hyperplastic process in 
which conjunctiva actively invades the cornea.
- A pseudo pterygium is the result of an inflammatory process and 
a fold of inflamed conjunctivabecoming adherent to a raw area on 
the cornea and being passively dragged across the cornea.  
           TRUE PTERYGIUM      PSEUDO PTERYGIUM
1.  Degenerative  &  hyperplastic  : 
Unilateral/bilateral. 
Post  inflammatory  process  : 
unilateral
2.  Is incorporated with the corneal 
tissue  throughout  extent  & firmly 
fixed at its apex
Adherent only at its apex
3.  Found in nasal & temporal side 
in the interpalpabral fissure
Found  on  any  part  of  corneal 
margin
4.  Probe  cannot  be  passed 
underneath
Probe can be passed underneath
5. Progressive or stationary Regresses after treatment
 
According to Doherty’s morphological classification, true pterygium 
is classified into
(1) Progressive
(2) Stationary
(3) Regressive
PROGRESSIVE PTERYGIUM
         Also called pterygium crassum, vasculosum or carnosum. Is 
actively growing, fleshy and vascular. The neck is hyperaemic, head is 
voluminous and of gelatinous appearance. The borders are very much 
serrated  and  infiltrating  healthy  cornea  and  usually  does  not  have 
stocker’s  line ahead of  it.  In  front  of  head,  numerous  infiltrations of 
cornea seen.
STATIONARY PTERYGIUM
          The head of pterygium looks pale and sparsely vascularised and 
stops growing. It losses its vascular appearance and develops a stocker’s 
line.
REGRESSIVE PTERYGIUM
           A pale, thin, papery, gray, anemic and membranous pterygium 
appears to be regressing, but in reality never gets smaller or disappears. 
Has a grey apex resembling corneal opacity. Usually seen in elderly and 
represent age related degenerative changes.  
Gerundo classified the above said first three stages as
• Proliferative papillomatous
• Fibromatous
• Atrophic – sclerotic
          In one study regarding pterygium morphology, pterygia have been 
classified  into  three  grades  based  on  the  relative  translucency  of 
pterygium tissue when seen through slit lamp.
             Grade T1 (atrophic) – episcleral vessels underlying the body of 
pterygium were unobscured and clearly distinguished.
             Grade T3 (fleshy) – a thick pterygium in which the episcleral 
vessels underlying the body of pterygium were totally obscured.
             Grade T2 (intermediate) – all other pterygia that did not fall into  
two categories, where episcleral vessel details were indistinctly seen or 
partly obscured.
              Pterygium vessels were distinguished from the episcleral 
vessels by the straightened radial orientation of vessels seen in pterygia.
RECURRENT PTERYGIUM
            Regrowth of pterygium after primary excision is called recurrent  
pterygium.  It  is  a  fibrovascular  tissue  growing  onto  cornea  without 
elastotic  degeneration.  It  involves  underlying  sclera,  episclera  and 
Tenon’s  capsule  and  grows  onto  corneal  stroma,  where  it  is  firmly 
adherent to underlying tissue. It can cause restriction of ocular motility 
due to scar tissue.
         Recently, Townseed classified pterygium into 5 groups depending 
on their risk of recurrence :
• Actively growing
• Fleshy
• Slowly growing
• Stationary
• Atrophic 
SITE
            Pterygium occurs mostly on the nasal part of conjunctiva (60%) 
being less common on the temporal side (20%).  Occasionally it can be 
double pterygia,  in  same eye seen both temporal  and nasal.  Even in 
double pterygia, the nasal pterygium is most commonly the first one to 
occur. It can affect one or both eyes.
           Various explanations have been put forth for greater predilection 
on nasal side.
1. The normal flow of tears is from temporal to nasal side towards 
the puncta. The tears carry dust particles which accumulate in the 
lacus  lacrimalis.  These  concentrated  dust  particles  may  cause 
greater irritation of nasal conjunctiva.
2. Greater exposure of nasal interpalpabral conjunctiva to ultraviolet 
radiation. ( Cameron 1865 )
3. Presence of two ciliary arteries on the nasal side and only one on 
temporal side, which leads to greater hyperemia on the nasal side 
in response to any irritant ( Wolf 1950 )
4. Excess subconjunctival tissue on the nasal side when compared to 
temporal.
5. Greater  curvature of  nasal  fibres of  orbicularis  oculi  causing a 
greater  squeezing  effect  upon  the  nasal  subconjunctival  tissue 
(Sugar 1949 )
6. Greater  bowing  of  lateral  1/3rd of  upperlid  and  consequence 
protection by longer lashes ( Cameron 1865 ).
AETIOPATHOLOGY OF PTERYGIUM
AETIOLOGY
The exact etiology is unknown. 
1. Heredity and genetics
Heredity  has  an  undoubted  role  in  the  occurrence  of  pterygia.  Duke 
Elder  (1965)  has  stated  that  the  mode  of  inheritance  is  autosomal 
dominant with low penetrance. This however does not mean that every 
pterygium occurs as the result of hereditary factors. Pterygium can also 
originate  as  an  acquired  pathological  condition  excited  by  external 
factors.  It appears possible that hereditary disposition to pterygia will 
only become manifest if there exciting factors.
2. Tear film and heat
 In some geographic areas where pterygia are prevalent , dust, wind 
and excessive dessication often coexist with solar glare. Tear function 
abnormalities  have  been  proposed  as  an  etiological  factor.  But  no 
abnormalities  of  schirmer’s  test,  tear  breakup  time  or  Rose  Bengal 
staining of cornea were found in eyes with pterygia compared to those 
without.  Pterygium incidence is high in some areas of high humidity 
where dessication is less likely. However, Elliot (1961) has pointed out 
that tear drying in areas of hogh humidity can occur due to constant 
exposure to wind leading to devitalisation of tissues in the medial third 
of  the  palpebral  aperture.  Anderson  (1954)  postulated  a  causal 
relationship between temperature and pterygium.  Other  workers have 
implicated infrared radiation but the evidence for this is weak.
3. Microtrauma
Mechanical irritation by dust particles, enhanced by tear flow from 
lateral to nasal has been proposed as a mechanism. However pterygia 
occur in dust free areas, for example at sea in sailors (Legwold 1983).
4. Angiogenesis factor
 It has been suggested that a pterygium angiogenesis factor may 
exist  which develops following repeated irritation at  the limbus.  The 
presence  of  this  factor  produces  vascular  ingrowth and formation  of 
pterygium  (WE  Wong  1978).  It  may  be  that  prolonged  ultraviolet 
exposure  causes  biological  changes  in  the  Bowman’s  membrane  and 
that  altered  proteins  so  formed  could  then  act  as  angiogenic  or 
pterygiogenic factors.
5. Immunology
IgE and IgG deposits in pterygium connective tissue stroma have 
been  described  (Pinkerton  Ajo  1984).  Plasma  cell  and  lymphocyte 
infiltration were seen in the same areas as antibody deposits. Cell bound 
IgE irritant complexes may initiate the release of active pharmacological 
mediators from mast cells which may in turn release stimulatory factors 
leading  to  the  development  of  pterygium.  Suggested  mediators  were 
platelet activating factor and platelet derived growth  factor.
6. Miscellaneous
It  has  been  proposed  that  a  factor  in  the  adult  forehead 
perspiration,  perhaps  lactic  acid,  commences  a  chain  of  events  in 
pterygium formation. Sweat flows along the brow, down the side of the 
nose and is deposited on nasal bulbar conjunctiva. This theory, however 
could not explain the occurrence of pterygium on situations where sweat 
would evaporate rapidly or in cold environments.
Other theories which have not gained ready acceptance include
• The notion that pterygium is due to a chronic infection
• That pterygium is due to thrombosis of conjunctival veins.
• That contraction of horizontal recti results in stasis in blood 
vessels  and looseness of  conjunctiva which folds itself  over 
the cornea forming a pterygium
• That light is reflected from the skin of the nose back on to the 
nasal limbus.
These various theories do not provide a convincing explanation of 
pathogenesis, shape or location.
7. Ultraviolet rays
 There  is  strong  circumstantial  evidence  that  exposure  to 
ultraviolet light is important in the etiology of pterygium. As pointed out 
by  Cameron  (1965)  ,  pterygium  is  most  common  between  latitudes 
40deg north and 40deg south, paralleling local atmospheric ultraviolet 
energy  intensity.  Confirmatory  evidence  for  the  involvement  of 
ultraviolet radiation has been gained by examining three risk groups
• Those known to be exposed to high levels of ultraviolet radiation 
( either outdoors or occupational ).
• Those  with  other  diseases  known to  be  induced  by  ultraviolet 
radiation.
• Subjects who may be hypersensitive to ultraviolet radiation.
          A study of pterygium in rural  Australians (BJO 1984) has 
demonstrated a strong positive correlation between climatic ultraviolet 
radiation  and  pterygium  prevalence.  Further  evidence  for  the 
involvement of ultraviolet light in aetiology of pterygium comes from 
the  systemic  associations  of  pterygium.  These  include  Basal  cell 
carcinoma,  Porphyria cutanea tarda,  Polymorphous light eruption and 
Xeroderma  pigmentosum.  Although  the  evidence  for  involvement  of 
ultraviolet  light  is  strong,  the  precise  mechanism by which it  causes 
pterygium and the  predominantly  nasal  location  cannot  be  explained 
convincingly.
8.  Role of limbal stem cells
           In recent years, improved results with various conjunctival 
autografting  techniques  including  the  limbal  tissue  have  led  to  the 
implication of the limbus stem cells in the aetiology and pathogenesis of 
the pterygium.
           Limbal stem cells are epithelial progenitor cells located in the  
basal layers of the peripheral cornea particularly at the limbus. These 
cells  are  responsible  for  corneal  epithelial  regeneration  and  trans 
differentiation and serve to replenish the loss of corneal epithelial cells 
through attrition and desquamation by proliferation and migration. They 
also serve as barrier to prevent conjunctival ingrowth onto the cornea. 
Of  the  many  histopathologic  features,  ‘conjunctivalisation’,  that  is 
invasion of conjunctival epithelial cells onto the corneal surface is the 
hallmark of stem cell deficiency. It appears that pterygium may be the 
result  of  localised damage to nasal  and temporal  limbal  cells  caused 
either by ultraviolet radiation or other environmental factors. Damaged 
limbal  cells  besides  loosing  their  barrier  function  ,  may  also  release 
vasoproliferative substances that encourage pterygium occurrence.
HISTOPATHOLOGY OF PTERYGIUM 
              Pterygium is the result of corneal rather than conjunctival 
disease since the first event in its formation is the appearance of minute 
opacities in the periphery of Bowman’s membrane in the interpalpebral 
area. These opacities are non inflammatory and occur at points where 
the corneal nerves penetrate the Bowman’s membrane. Following their 
appearance, the conjunctival sub epithelial connective tissue invades the 
superficial  cornea  fragmenting  and  destroying  Bowman’s  membrane. 
This invading connective tissue is covered by conjunctival epithelium 
and is covered by many thin walled vessels.
            According  to  Greer’s  ocular  pathology,  drying  of  the 
interpalpebral  tear  film  is  an  important  initiating  factor  in  the 
pathogenesis  of  pterygium.  This  exposes  the  peripheral  corneal 
epithelium, Bowman’s membrane and the underlying corneal stroma to 
the destructive effects of ultraviolet radiation.
           Drying of the interpalpebral tear film is most marked in the 
medial one third of interpalpebral fissure. Drying of tear film occurs not 
only in conditions of low atmosphere humidity but also when there is 
habitual exposure to constant wind.
           Exposure to high doses of  ultraviolet radiation causes nuclear 
fragmentation and cell death in corneal epithelium resulting in punctate 
epithelial  erosions  stainable  by  1%  rose  bengal  stain.  Repeated 
exposures  result  in  formation  of  punctate  ulcers  which  uncover 
Bowman’s  membrane.  After  prolonged  exposure  to  ultraviolet  light, 
holes  appear  in  the  Bowman’s  membrane  (COLANDER 
DEGENERATION  )  beneath  the  areas  of  epithelial  necrosis  and 
underlying  corneal  stroma  becomes  edematous.  These  peripheral 
corneal  changes  stimulate  invasion  by  blood  vessels  and  fibroblasts 
from the limbus, hastened by such factors as chronic infection or dust 
which  increase  corneal  vascularity.  Subsequent  organisation  of  this 
fibrovascular tissue causes traction which draws the characteristic wing 
of conjunctival tissue on to the cornea.
             The presence of colander degeneration of Bowman’s membrane  
and oedema of overlying stroma at the apex of the pterygium indicate 
that  the  degenerative  process  is  still  active  and  that  pterygium  is 
progressing.
            Histopathology of pterygium is thoroughly outlined by Fuch’s in  
1980s.  Electron  microscopic  findings  show  increased  number  of 
thickened  elastic  fibres,  hyaline  degeneration  of  conjunctival  tissue, 
concretion and epithelial changes. 
   Austin et al summarised the features as follows: 
• Hyalinasation  of  subepithelial  connective  tissue  of  substantia 
propria
• Diffuse  or  lobular  collection  of  eosinophilic  granular  material 
with  an  associated  increase  in  number  of  fibroblast  and  other 
cells.
• Increased  number  of  thickened  and  tortuous  fibres  that  stain 
strongly with elastic stains ( elastotic material )
• Concretions  within  the  hyalinised  and  granular  areas  that  may 
show either eosinophilia or basophilia.
   In reference to characteristic elastotic material within pterygia, the 
term ‘elastotic  degneration’  was  coined  to  describe  the  condition  of 
tissue uptake by Weigert’s and Verhoff’s elastic tissue stains.
               Historically, Hogan and Alvarado stated that elastotic material 
within pterygia is formed from four sources
• Degenerating collagen
• Preexisting elastic fibres
• Abnormal fibroblastic activity
• Abnormal ground substances
                More recently ultrastructural analysis by Austin et al 
attributed  the  elastotic  degeneration  solely  to  abnormal  fibroblastic 
activity with the production of abnormal maturational forms of elastic 
fibres.  The  fibroblasts  originate  from  the  limbal  connective  tissue. 
Moreover collagen degeneration was only demonstrated in subepithelial 
zone  and  accounted  for  light  microscopic  finding  of  hyaline 
degradation.
               Histopathologic analysis of leading edges of pterygia by 
Cameron disclosed the following
1. Fibroblastic tissue separating basal corneal epithelial layers from 
Bowman’s layer.
2. Altered orientation of basal corneal epithelial cells overlying the 
fibroblastic  tissue.  They  are  elevated  and  their  normal  vertical 
axis becomes oblique.
3. Destruction  of  Bowman’s  layer  and  superficial  corneal  stroma 
underlying fibroblastic tissue. Fibroblasts are found in the area of 
tissue  destruction  closely  applied  to  the  edges  of  Bowman’s 
membrane.  Their  nuclei  are  elongated  and  irregular  with 
numerous nuclear pores.
4. Normal corneal tissue proximal to leading edge of pterygium.
               Immunohistochemical staining has demonstrated presence of 
altered limbal  basal  stem cells  between dissolved edge of Bowman’s 
layer and fibrovascular tissue of pterygia. Other histologic changes that 
have been identified in  epithelium of pterygia include squamous cell 
metaplasia, acanthosis and dyskeratosis. 
               A recurrent or secondary pterygium is defined as recurrence of 
pterygium after primary surgical excision. A secondary pterygium often 
has  more  exuberant  fibrovascular  growth  response  than  original 
pterygium. The histology findings of secondary pterygium differ from 
primary  pterygium in  that  the  typical  degenerative  connective  tissue 
changes  are  absent.  Cameron  suggested  that  surgical  trauma  after 
primary  excision  leads  to  an  accelerated  fibrovascular  proliferative 
response.
             The cytology of surface cells overlying pterygium is abnormal 
typically  exhibiting  squamous  metaplasia  with  increased  goblet  cell 
density.  Abnormal  cytology  is  also  demonstrable  in  inferior  bulbar 
conjunctiva.  This  suggests  a  graded series  of  ocular  surface  changes 
occurring  throughout  the  bulbar  conjunctiva  with  most  advanced 
changes  occurring  directly  over  pterygium  surface  confirming  that 
pterygium is indeed an ocular surface disorder. 
STUDY OF CELL CYCLE KINETICS IN PTERYGIUM
             A study on cell cycle kinetics in pterygia has shown that cellular 
proliferation is not significantly greater in pterygia when compared to 
normal conjunctiva. Also, cellular proliferation patterns of primary and 
recurrent pterygia are not significantly different from each other. The 
findings suggest that pterygium is not a disorder of cellular proliferation. 
It  is  probably caused by excessive  production of  extracellular  matrix 
(or)  by  lack  of  enzymes  such  as  collagenases  leading  to  tissue 
accumulation.  The implication of the above findings is that  therapies 
should be directed towards regulation of extracellular matrix production 
rather  than  antimitotic  approaches  such  as  mitomycin  and  beta 
irradiation.  (Cell  cycle  kinetics  in  pterygium  at  three  latitudes  BJO 
1995)
CLINICAL FEATURES OF PTERYGIUM
            Pterygium is a fibrovascular, wing shaped encroachment of 
conjunctiva  onto  the  cornea.  For  the  purpose  of  description  the 
pterygium is divided into four parts
1. Head – the part invading the cornea from limbus
2. Apex – the most interior portion of head in the cornea
3. Body – the widest portion found on bulbar conjunctiva
4. Neck – the narrowest part, the junction of the head and the body 
of the pterygium.
            The head and the apex are firmly blended with the cornea. The  
body has got attachments to the episclera, lesser than its surface area. 
Hence a probe can be made to pass behind the body about a mm or so 
but not completely underneath it.
           Clinically the pterygium can be classified as follows:
1. Early pterygium – A small  and fleshy pterygium with minimal 
encroachment  on  the  cornea.  Few corneal  infiltrations  may  be 
found in front of the apex.
2. Progressive  pterygium  –  A  progressive  pterygium  is  fleshy, 
vascular  and  occasionally  may  get  violently  hyperaemic  at  its 
head.  There  are  infiltrations  in  front  of  the  apex  (  FUCH’S 
SPOTS ).
Microscopically  the  progressive  pterygium  is  characterised 
bycolander  degeneration  of  the  Bowman’s  membrane  (presence  of 
holes) and edema of underlying stroma at apex of pterygium.
STOCKER’S LINE  
Immediately in front of the apex, a pigmented line is seen due to 
pooling  of  tears  in  areas  where  corneal  surface  is  irregular. 
Histologically iron is found within the basal epithelial cells and can be 
demonstrated  using Prussian  blue stain or  Perl’s  test.  This  line is  an 
indicator of chronicity of pterygium.
When the pterygium ceases to grow, the vascularity disappears 
and it appears thin,grey,anaemic and membranous but never disappears.
3. Malignant  pterygium  –  The  progression  is  faster  so  that  a  fleshy 
highly vascular growth encroaches the cornea over a larger area in a 
comparatively  shorter  duration  of  time.  It  is  termed  as  malignant 
because of its exuberant growth. This is common in young individuals.
4. Atrophic  pterygium  –  When  the  pterygium  inducing  factors  are 
withdrawn  from  exerting  their  influences,  the  pterygium  can  stop 
growing characterised by reduction of vascularity, pale flat appearance 
and no infiltration in front of the apex. The vessels become straight due 
to fibrous tissue contraction. Atrophic pterygia are commonly seen in 
old patients with long standing pterygium.   
SIGNS AND SYMPTOMS
• Many pterygia may remain asymptomatic
• Irritation, watering and foreign body sensation
• Pain may be present during inflammation
• Reduced visual acuity may be due to obstruction of visual 
axis or due to astigmatism
Astigmatism  :  as  the  pterygium  progresses,  it  causes 
flattening of the corneal curvature in its horizontal meridian 
producing an hypermetropic astigmatism of about +0.75D 
to +1.50D which is with the rule
• Cosmetic disfigurement
• Problems in contact lens fitting
• Restriction of ocular movements (abduction) from traction 
on the conjunctiva. It may lead to diplopia in some.
MANAGEMENT
          Medical management has been tried from the earliest times, but  
found to be unsatisfactory. Topical steroids, sub conjunctival injection 
of hyaluronidases, cryotheraphy and lasers have been used but with little 
success.  Currently  the  use  of  steroids  is  limited  to  the  postoperative 
control of inflammation and fibrovascular proliferation.
         Surgical excision remains the principle mode of treatment for 
pterygium. A variety of surgical techniques have been tried and their 
evolution has been based on the sole aim of preventing recurrence. The 
existence of a number of surgical techniques attests to the fact that no 
single technique has been universally successful.
INDICATIONS FOR SURGERY
1. Decreased visual acuity
-    due to encroachment into visual axis
-    induction of progressive irregular astigmatism
2. Ocular irritation and discomfort
3. Recurrent inflammation
4. Cosmetic disfigurement
5. Restricted ocular motility
6. Binocular diplopia
7. Difficulty in performing corneal refractive surgeries
8. Difficulty in contact lens fitting.
The surgical techniques have been broadly classified into
• Excisions
• Transpositions
• Plastic repairs
EXCISIONS
SIMPLE EXCISION :
          It is one of the earliest methods. It was refined by Czemark and 
Arlt. This is the simplest method and consists of extirpation of the entire 
fibrovascular tissue and suturing the two free lips of conjunctiva. The 
technique  may  be  used  in  the  simplest  of  the  cases,  these  being 
determined  on  the  basis  of  annoyance  to  the  patient  rather  than  the 
nature of the pterygium.
BARE SCLERA EXCISION :
           This technique was popularised by D’ombrain ( 1948 ). The 
pterygium was excised  along with  a  part  of  the conjunctiva,  leaving 
behind an area of bare sclera between the edge of the conjunctiva and 
the  cornea.  This  technique  is  based  on  the  principle  that 
reepithelialisation of the denuded cornea will  be accomplished before 
resurfacing of the bare scleral area by conjunctival epithelium. Though 
it is one of the widely used procedures, it is known to be associated with 
a high recurrence rate.
TRANSPOSITIONS
           It was formerly thought that the head of the pterygium is the  
cause  for  recurrence.  Desmarre  first  transplanted  the  head  of  the 
pterygium by carrying down into a conjunctival slit below and suturing 
it  as  a  pedicle  flap.  Desmarre’s  technique  was  modified  by  Mc 
Reynolds.
          Mc Reynolds operation consists of transplanting the head of the 
pterygium beneath the conjunctiva without  cutting it  and fastening it 
with sutures near the insertion of inferior rectus.
PLASTIC REPAIRS
PRIMARY CLOSURE OF CONJUNCTIVA
      The idea of bringing healthy conjunctival tissue to the dissected 
limbal  area  to  prevent  recurrence  has  led  to  several  forms  of 
conjunctival closure
• SLIDING  FLAP  PROCEDURE  –  McCoombs  et  al  in  1994 
found this procedure in which a rectangular flap of conjunctiva is 
undermined  and  retracted  down  into  the  defect  created  by 
pterygium  excision.  Recent  study  showed  45%  recurrence  of 
primary repair
• THE MEREST SCLERA TECHNIQUE – In this, the pterygium 
is  excised  from the  overlying conjunctiva  and  sclera,  and the 
superior and inferior flaps are brought together to minimize bare 
sclera and sutured with 10-0 nylon sutures.  Recurrence rate is 
2.1%.  All  cases  were  associated  with  graft  dehiscence  or 
infection.
• Z PLASTY – The pterygium body is directed into the defect by a 
V  shaped  conjunctival  flap  which  itself  is  sutured  along  the 
limbus. Recurrence rates are high. 
CONJUNCTIVAL AUTOGRAFT TRANSPLANTATION
      Majoros was the first one to describe free conjunctival grafts for 
pterygium.  Thoft  and  later  Vastine  et  al.  described  conjunctival 
autografting  for  several  ocular  surface  disorders  such  as  unilateral 
chemical  or  thermal  burns,  irradiational  injury,  neoplasms,  persistent 
epithelial defects,  trauma, fornix reconstruction, cicatricial strabismus, 
developmental anomalies and degenerative diseases including pterygia.
       Kenyon et  al.  (1985)  described the  technique  of  conjunctival 
autografting in detail and popularised it not only for recurrent pterygium 
but also for advanced primary pterygia. The surgical technique involves 
transferring  a  free  graft  of  superior  bulbar  conjunctiva  to  cover  the 
sclera exposed by pterygium excision and fornix reconstruction.
Surgical technique
• After local anaesthesia,  a rigid lid speculum is used to provide 
maximal exposure. Stay sutures of 4’0 black silk are inserted at 
the 12’0 clock and 6’0 clock limbus.
• The  eye  is  abducted  maximally  (assume  nasal  pterygium)  and 
multiple cautery spots are used to delineate the involved area of 
conjunctiva to be excised.
• Beginning at the head of pterygium a disposable scarifier is used 
to superficially excise the involved cornea to the limbus. Spring 
action  scissors  are  used  for  complete  circumcision  of  the 
conjunctiva at the cautery marks.
• With  blunt  dissection,  the  conjunctiva  and tenon’s  capsule  are 
freed from the horizontal rectus muscle. Extraocular muscles are 
identified  with  muscle  hook  and  if  necessary  isolated  with 
traction  sutures.  Especially  in  recurrent  cases  the  muscles  can 
become  enmeshed  in  scar  tissue  and  unless  dissected 
meticulously, can be damaged or severed.
• Complete  resection  is  done  of  involved  conjunctiva,  Tenon’s 
capsule and cicatrix; the bare sclera and muscle remains exposed. 
The adjacent limbus and cornea are polished with a diamond burr.
• Conjunctival margins are recessed to restore fornix. Conjunctiva 
is sutured to sclera with absorbable suture on spatula needle.
• The size of conjunctival graft required to resurface the exposed 
sclera is measured with calipers.
• The globe is rotated inferomedially to access uninvolved superior 
bulbar conjunctiva. Dimensions are marked.
• With sharp, spring action scissors the conjunctiva is dissected out 
as thinly as possible, leaving the Tenon’s capsule and episcleral 
tissue  undisturbed.  By  doing  so,  the  donor  site  need  not  be 
sutured  and  would  heal  without  scarring.  Also,  a  thin  graft  is 
more elastic and heals with less shrinkage.
• The  eye  is  abducted  and  the  free  graft  is  mobilised  into  the 
recipient bed. The graft is secured to the surrounding conjunctiva 
and episclera with interrupted sutures.
Postoperatively  topical  steroids  and  antibiotics  are  applied 
frequently.  Conjunctival  autografting  reduces  the  recurrences  of 
pterygium bt the following mechanisms
1. Conjunctival  autograft  taken  from  supero  temporal  bulbar 
conjunctiva  provides  less  exposed  conjunctiva  with  intact 
basement membrane.
2. Complete  closure  of  the  excision  site  with  relatively  normal 
conjunctival tissue provides a “fire break” to the proliferation and 
advancement of residual abnormal tissue, both conjunctival and 
episcleral towards and across the limbus.
3. Limbal  stem cells are included in the conjunctiva and are then 
correctly oriented at the limbus of the pterygium excision site.
Advantages of conjunctival autograft transplantation
• Offers anatomical and physiological restoration of ocular surface
• Reduces recurrent rates
• Useful in both advanced and recurrent pterygium
• Does not require additional surgical skill or instrumentation
• Avoid  serious  complications  of  antimitotic  agents  or  beta 
irradiation
• Does not require any special post operative care.
LIMBAL CONJUNCTIVAL AUTOGRAFT 
TRANSPLANTATION (LCAT)
          Despite the established efficacy of conjunctival autografting in 
reducing the recurrence of pterygium, some of the studies have reported 
a  higher  rate  of  recurrence  between  21  and  39%.  It  is  the  latest 
technique in management of pterygium. The technique is based on the 
concept that  the pterygium is a localised disorder of the limbal  stem 
cells brought about by environmental factors. The surgical technique is 
similar to that of conjunctival autografting except for the fact that the 
limbal conjunctiva is included in the graft. Srinivas et al  (IJO Vol 46, 
No.4 September 1998) have reported the superiority of limbal autograft 
over conventional autograft in preventing recurrence.
PROBLEMS AND COMPLICATIONS
INTRAOPERATIVE
• Thick graft : Thick graft results due to inclusion of Tenon’s capsule 
along with conjunctiva.  It  causes graft  oedema and graft  rejection 
postoperatively.
• Incorrect graft placement : The graft may be inadvertently inverted 
such  that  the  epithelium is  apposed  to  the  sclera.  The  graft  will 
certainly  slough off  if  it  happens.  To avoid this  complication  the 
epithelial surface should be marked with gentian violet or cautery.
• Graft orientation : The graft should be placed in such a manner that 
the limbal side of donor conjunctiva corresponds with the limbus of 
host bed.
• Inadequate graft size : If the graft size is smaller than the bare area, 
the sutures may cut through the conjunctiva due to excessive tension. 
Inadequate  grafts  may  shrink  and  retract  resulting  in  pterygium 
recurrence due to loss of barrier function.
• Poor quality of graft : The quality of graft may be poor in patients 
with  previous  trauma,  surgery,  infection,  chronic  inflammation, 
xerosis resulting in excessive fibrosis and cicatrisation.
• Excessive  surgical  manipulation  :  Excessive  surgical  manipulation 
causes  drying  and  shrinkage  of  conjunctiva  which  may  result  in 
recurrence.
POST OPERATIVE
• Graft oedema : Graft oedema occurs due to excessive manipulation, 
inclusion of Tenon’s capsule, poor graft orientation and haematoma 
of the graft. It may resolve within 2 to 4 weeks.
• Haematoma  :  Haemorrhage  within  or  under  the  graft  may  occur 
during  surgery  or  postoperatively.  This  usually  occurs  due  to 
inadequate  hemostasis  of  the  episcleral  and  Tenon’s  conjunctival 
tissues.
• Conjunctival graft necrosis : Two main causes of graft necrosis are 
incorrect placement of graft and avascular scleral bed. Inverted graft 
becomes pale within 24 to 48 hrs and the scleral  bed is  exposed. 
Avascular  scleral  bed  is  seen  in  patients  with  previous  beta 
irradiation.
• Conjunctival  graft  retraction  :  main  causes  of  graft  retraction  are 
inadequate graft size, excessive Tenon’s tissue and poor graft quality.
• Corneo scleral dellen : Main causes of dellen formation are excessive 
graft oedema and irregular surface due to excessive use of diamond 
burr polisher.
• Granuloma  :  Post  operative  granuloma  at  the  donor  site  is  fairly 
common. It is basically a Tenon’s granuloma. Granuloma may occur 
at the host site also. The treatment is simple excision.
• Symblepharon : Gupta and Chen (1995) have reported symblepharon 
formation after conjunctival autografting.
• Corneal astigmatism
• Epithelial inclusion cysts are infrequent
• Extraocular muscle disinsertion.
AMNIOTIC MEMBRANE ALLOGRAFT TRANSPLANTATION
       Panzardi  first  performed  amniotic  membrane  grafting  after 
pterygium excision in 1947.
      The hyperproliferative nature of subconjunctival  fibroblasts can 
result in fibrosis with accelerated growth of recurrent pterygium after 
primary pterygium removal.  It  is  hypothesised  that  transplantation of 
preserved human amniotic  membrane suppresses  postsurgical  fibrosis 
and fibroblast proliferation, lowering recurrence rate.
      With advances in  preservation in  Dulbecco’s modified  Eagle’s 
culture medium and glycerol stored in –80degree C, the problem of graft 
rejection  is  solved.  Suppression  of  inflammation  is  important  in 
preventing  scar  formation  and  recurrence.  Amniotic  membrane 
transplantation maintains normal conjunctival epithelium which makes 
it superior to buccal or mucous membrane grafts.
       It has been suggested that amniotic membrane transplantation is 
more successful  in preventing recurrence if  the graft  is  covered with 
either limbal or conjunctival autograft transplants. The recurrence rates 
with this method was from 10.7 to 15.4%.
ADJUNCTIVE TREATMENT
BETA IRRADIATION
          Castroviejo was optimistic about the combination of surgical 
excision  and  adjunctive  beta  irradiation.  Radiation  causes  ionization 
changes  in  both  the  nucleus  and  cytoplasm  of  cells.  Tissues  with 
neovascularisation and fibroblasts, which are responsible for pterygium 
recurrence are the most susceptible to irradiation during their peak of 
mitotic activity, division and proliferation. Irradiation causes obliterative 
endarteritis and arrest of fibroblast proliferation. Use of Strontium-90 is 
the  safest  and  most  effective  mode  of  irradiation  to  the  eye.  The 
standard applicator delivers approximately 3000 reps per minute over its 
entire radiation surface. But the complications like cataract formation, 
keratitis  sicca,  episcleritis,  iritis,  corneal  thinning,  ulceration,  scleral 
ulceration and pseudomonas  endophthalmitis  occurs in  high doses  or 
repeated usage. The recurrence rates varies from 0.5% to 33%.
ANTIMETABOLITES
THIOTEPA
Thiotepa ( triethylene thiophosphoramide ) is a radiomimetic drug 
of the nitrogen mustard family. Mecham first used the drug in 1962 for 
recurrent pterygium as a 1:2000 (0.5mg/ml) solution every 3 hours for 6 
to  8  weeks.  They  have  their  action  on  actively  dividing  cells  by 
releasing  ethylenimine  radicals  causing  inhibition  of  capillary 
endothelial proliferation. Though reduced recurrence rates upto 4% were 
recorded,  the  complications  like  poliosis  and  periorbital  skin 
depigmentation,  especially  in  dark-skinned individuals  has limited  its 
usage. It is rarely used nowadays. 
MITOMYCIN C
            Mitomycin is an antibiotic-antineoplastic and antimetabolite 
agent isolated from the fermentation filtrate of streptomyces caespitosus. 
It  selectively  inhibits  DNA  replication  by  forming  covalent  bonds 
between adenine and guanine,  and it  is non cell  specific,  exerting its 
action  primarily  during  the  late  G1  and  S  phases  of  cell  division. 
However, rapidly dividing cells are preferentially sensitive to the effects 
of  Mitomycin C.
         Kunimoto and Mori was the first to use it in treating pterygium in 
1963.  It  is  also  used  in  Glaucoma  filtering  surgery,  in  treatment  of 
conjunctival  and corneal  intraepithelial  neoplasia,  in ocular cicatricial 
pemphigoid, in wound healing after photorefractive keratectomy, and in 
nasolacrimal duct surgeries. 
Mitomycin C is used by two modes
Postoperative Topical MMC application:
        Initially topical MMC in 1mg/ml (0.1%) after primary pterygium 
excision,  instilled  4  times  a  day  for  10  days  caused  lower  lacrimal 
punctual  occlusion,  mild  superficial  punctate  keratitis,  iritis  and  a 
recurrence rate of 5% after 5months followup.
        Subsequently, lower concentrations in 0.04% and 0.02% were 
studied  with  lower  complications.  Postoperative  MMC  in  0.02% 
dilution used twice daily for 5 days lowered recurrence rate to 2.6% in 
1yr followup. The side effects encountered were avascularised sclera, 
ocular discomfort and lacrimation, superficial punctate keratopathy and 
pyogenic granuloma were all  mild, self limiting and easily treated.
Intraoperative MMC application:
        Conflicting  results  have  been  obtained  after  intraoperative 
application of   MMC. This  is  due to  adoption of  different  treatment 
protocols. Some of them used higher concentrations which still caused 
decreased recurrence rates.
- Intraoperative  application  of  0.05% MMC  for  1  minute  along 
with 20mg subconjunctival depot steroid injection resulted in no 
recurrence after 4 to 14 months followup. 
- Intraoperative application of 0.04% MMC for 3 mins decreased 
recurrence rate from 33% in control group to 6.7%.
Side effects and complications with topical MMC include
• Scleral thinning and perforation
• Secondary glaucoma
• Corneal perforation
• Iritis 
• Photophobia and pain.
However  these  adverse  effects  were  seen  after  prolonged  and 
unsupervised topical administration and in some cases the concentration 
was much higher than recommended.
Frucht-Pery and Ilsar demonstrated that lower concentration of 
MMC  administered  over  a  short  time  increases  safety  without 
compromising efficacy.
LAMELLAR KERATOPLASTY
       It  is  performed  as  an  adjunctive  procedure  to  treat  recurrent 
pterygium. The purpose was to replace the thinned and scared corneal 
tissue after pterygium excision and has been used as a barrier against the 
regrowth of pterygium.
       Magitot  was the first  to recommend keratoplasty in pterygium 
treatment (1916). Recurrence rates ranged from 5% to 55%. It has no 
special advantage in recurrence.
Recurrence rates with different surgical techniques for pterygia
Sl. 
No.
TECHNIQUE RECURRENCE 
RATE %
1. SIMPLE EXCISION 30 - 100
2. BARE SCLERA 5 - 89
3. AMNIOTIC  MEMBRANE GRAFT 10.7 – 15.4
4. CONJUNCTIVAL AUTOGRAFT 5 - 39
5. LCAT 2.3 – 13.3
6. BETA IRRADIATION 0.5 - 33
7. MITOMYCIN C (INTRAOP) 8.3 – 23%
8. LAMELLAR KERATOPLASTY 5 - 55
AIM OF THE STUDY
1. To  study  the  efficacy  and  safety  of  limbal  conjunctival 
autografting in the surgical management of pterygium.
2. To compare the recurrence rates and complications of limbal 
conjunctival autografting with primary conjunctival closure 
(Merest  sclera  technique)  and  adjuvant  use  of  MMC 
(Mitomycin C) with conjunctival closure.
                          MATERIALS AND METHODS
A  prospective  randomised  controlled  study  was  done  over  a 
period  of  12  months.  75  cases  of  pterygia  needing  surgery  who 
presented to Government Rajaji Hospital, Ophthalmology Department, 
Madurai from June 2008 to June 2009 were entered in this study. The 
patients were randomly divided into three groups irrespective of their 
age and sex.
Group  1 : 
hitherto  known  as  the  Merest  Sclera  group,  25  eyes  of  25 
patients  underwent  surgical  excision  of  pterygium by  Merest  Sclera 
technique (MST).
Group   2 : 
hitherto  known  as  LCAT  (Limbal  Conjunctival  Autograft 
Transplantation  )  group,  25  eyes  of  25  patients  underwent  surgical 
excision of pterygium followed by LCAT.
Group  3 : 
hitherto known as MMC ( Conjunctival closure with adjunctive 
Mitomycin  C  )  group,  25  eyes  of  25  patients  underwent  surgical 
excision of pterygium followed by adjunctive use of MMC in bare area 
followed by conjunctival closure with suturing.
INCLUSION CRITERIA
• Age > 18 years
• Progressive pterygia grade T2 and grade T3
• Primary & Stationary pterygia
• Eyes  with  no  evidence  of  any  ocular  surface  disorder,  any 
disorder of ocular adnexa or any major surgeries.
EXCLUSION CRITERIA
• Recurrent pterygia
• Atrophic pterygia and pterygia less than 2mm encroachment on 
cornea
• Eyes with evidence of any ocular surface disorder ( eg.Dry eye) 
or  any  ocular  adnexal  disorders  or  evidence  of  any  high 
intraocular pressure.
PREOPERATIVE ASSESSMENT
Preoperatively  uncorrected  and  corrected  visual  acuity  were 
recorded in all cases.
A  baseline  intraocular  pressure  measurement  was  done  in  all 
cases using schiotz tonometer.
A slit lamp examination was performed and a careful assessment 
of  the  morphology,  vascularity  and size  of  the  pterygium was  made 
along with careful examination of ocular adnexa and anterior segment.
The  size  of  pterygium  was  recorded  as  millimetres  of 
encroachment onto cornea from the limbus.
Orbital anatomy and normalcy of lid closure were noted.
SURGICAL METHODS
The  patients  were  all  operated  by  a  single  surgeon  under 
peribulbar block with 2% lignocaine.
The merest sclera technique was done by dissecting the head of 
pterygium from corneal surface starting o.5 to 1mm in front of its apex 
with a Bard Parker knife and no.15 blade upto the limbus. Then with the 
aid of spring action scissors the pterygium , after its separation from 
overlying conjunctiva  and underlying sclera  by  blunt  dissection,  was 
excised. Hemostasis secured by wet cautery. Then the upper and lower 
free ends of conjunctiva were brought together and sutured with 10-0 
nylon sutures.
The adjunctive use of Mitomycin C was applied in concentration 
of 0.02% with cotton tipped applicator for 3 minutes in the bare area 
after  pterygium  was  excised  by  above  said  method,  then  irrigated 
thoroughly with normal saline and then the conjunctival free ends were 
sutured over the area with 10-0 nylon.
The  limbal  conjunctival  autograft  was  done  after  excising  the 
pterygium as described above. Graft was obtained from superotemporal 
conjunctiva after marking the graft dimensions with the use of callipers 
with excision starting from forniceal end. Care was taken to obtain a 
thin graft without button holing. Once limbus was reached, graft  was 
flipped  over  the  cornea  and  tenon’s  attachment  at  limbus  was 
meticulously dissected. The flap was then excised with vannas scissors 
taking care to include the limbal tissue. Then graft was slid onto cornea 
without  lifting  and  moved  onto  scleral  bed  maintaining  the  limbus-
limbus orientation. The graft was smoothened out and secured using 10-
0 nylon sutures.
The eye was then patched with antibiotic ointment.
POSTOPERATIVE CARE AND FOLLOW UP
Postoperatively topical dexamathasone eye drops was used every 
2 hrs for the first postoperative week and then tapered over the next 5-6 
weeks.  Topical  NSAIDS  were  used  according  to  patient 
symptomatology.
After the immediate postoperative period, patients were seen at 6 
weeks, 3 months, 6 months and 1 year.
During  each  visit  patient  was  subject  to  visual  acuity 
measurement,  IOP measurement and careful slit lamp examination. A 
recurrence was defined as fibrovascular tissue crossing the corneoscleral 
limbus onto clear cornea in the area of previous pterygium excision.
ANALYSIS AND RESULTS
AGE DISTRIBUTION
AGE GROUP (IN YEARS) NO OF 
CASES
PERCENTAGE
        LESS THAN 30 9 12
        30 - 39 21 28
        40 - 49 23 31
        50 - 59 19 25
        60 & ABOVE 3 4
             TOTAL 75 100
     Out of 75 patients analysed, a total of 59% patients were in 30 to 
50 years age group and 25% patients were in 50 to 59 years age group. 
This  age  distribution  nearly  correlates  with  literature  stating  that 
pterygium is  more common in elderly with a  increase  in  age groups 
between 20 and 40years.
SEX DISTRIBUTION
SEX NO OF PATIENTS PERCENTAGE
MALE 44 59
FEMALE 31 41
TOTAL 75 100
           Majority of patients in the study group were men. This correlates 
with literature which states that pterygium is twice as common in males 
as in female patients. This has been attributed to the fact that men are 
likely to remain outdoors more often than women and have an increased 
risk of exposure to sunlight.
LATERALITY
EYE AFFECTED NO OF PATIENTS PERCENTAGE
RIGHT EYE 35 47
LEFT EYE 28 37
BOTH EYES 12 16
 
     The pterygium was present on the right eye in 47% and on the left 
eye in 37% of patients. 16%  had bilateral pterygium. Pterygium is most 
commonly a bilateral condition. One eye may follow the other by 
months to years.
LOCATION OF THE PTERYGIUM
SITE NO OF PATIENTS PERCENTAGE
NASAL 72 96
TEMPORAL 1 1.33
DOUBLE 2 2.66
TOTAL 75 100
          92% of pterygia were present on the nasal side, the predominantly 
nasal location of pterygia has been attributed to greater exposure of the 
nasal interpalpebral conjunctiva to ultraviolet radiation. 5% patients had 
double pterygia, which might indicate a more widespread actinic 
damage of the limbal cells.
SIZE OF PTERYGIUM
SIZE VALUE (MM)
RANGE 2 – 4.5
MEAN 2.66
                     
     The pterygia included were of a mean size of 2.66mm, which are 
progressive and stationary primary pterygia of grade T2 and T3.
INDICATION FOR SURGERY
INDICATION NO OF 
PATIENTS
PERCENTAGE
COSMETIC DISFIGUREMENT 24 32
OCULAR IRRITATION 29 38
RECURRENT INFLAMMATION 11 15
VISUAL IMPAIRMENT 11 15
TOTAL 75 100
         The commenest indication for surgery in this study group were 
ocular irritation (38%) and cosmetic disfigurement (32%). Pterygium 
is  commonly  blamed  for  eye  irritation,  foreign  body  sensation, 
dryness,  epiphora  and  pruritis.  They  are  in  reality  caused  by 
underlying  dry  eye.  Even  a  small  pterygium may  cause  cosmetic 
blemish to the patient. Pterygium may also become inflamed causing 
episodic inflammation,  pain and tenderness.  Pterygium causes with 
the rule astigmatism due to horizontal flattening and also obstructs 
peripheral vision on encroaching near papillary aperture.
PROCEDURE
PROCEDURE NO OF CASES PERCENTAGE
GP 1 - MST 25 33.3
GP 2 - LCAT 25 33.3
GP 3 - MMC 25 33.3
TOTAL 75 100
      All three groups had equal number of patients, 25 eyes were 
operated in each group.
PROCEDURE AND LOCATION
 PROCEDURE      NASAL   DOUBLE   TEMPORAL
      MST           23           2             1
     LCAT           25           -             -
      MMC           25           -             -
FOLLOW UP
    The average follow up period was 6 months to 18 months. 90% of the 
patients  were  followed  up  for  18  months.  2  patients  in  Group  1,  3 
patients in Group 2, and 3 patients in Group 3 were lost follow up after 
12months.
RECURRENCE RATES
GROUP NO OF EYES 
OPERATED
NO OF 
RECURRENCES
PERCENTAGE
GP 1 - MST 25 5 20
GP 2 - LCAT 25 3 12
GP 3 - MMC 25 4 16
TOTAL 75 12
          The total number of recurrences were 12 out of which 5 
occurred  in  merest  sclera  technique  group,  3  occurred  in  limbal 
conjunctival autograft group and 4 occurred in mitomycin C group. 
The recurrence rates in the three groups were 20%, 12% and 16% 
respectively.  
TIME OF RECURRENCE
TIME GP 1 GP 2 GP 3 TOTAL %
0 – 6 wks - - - - -
6 wks – 3 mths 3 1 3 7 58
3 – 6 mths 1 1 1 3 25
6 mths –12mths 1 1 - 2 17
12mths –18mths - - - - -
            58% of all recurrences occurred between 6 weeks and 3 
months after surgery. 25% of recurrences occurred between 3 to 6 
months after surgery. 17% of recurrences occurred between 6 months 
to one year. No recurrences were found before 6 weeks and after 12 
months.
AGE AND RECURRENCE
AGE GPS GP 1 GP 2 GP 3 TOTAL %
0 - 20 - - - - -
21 - 40 - - 1 1 8
41 - 60 5 3 3 11 92
>60 - - - - -
TOTAL 5 3 4 12
         In this study more recurrences were found in the age group of 40 
to 60 years. 8% occurred in 21-40yrs age group. 
COMPLICATIONS
GPOUP 1
S No COMPLICATIONS NO OF PATIENTS
   1. GRAFT DEHISCENCE 1
   2. GRAFT INFECTION 1
   3. SUTURE IRRITATION 1
   4. SUTURE SITE GRANULOMA 1
GROUP 2
S No COMPLICATIONS NO
   1. GRAFT RETRACTION 3
   2. SUTURE IRRITATION 2
   3. DONOR SITE GRANULATION 1
   4. CORNEAL DELLEN 1
GROUP 3
S No COMPLICATIONS NO
   1. AVASCULARITY NEAR LIMBUS 1
   2. RAISED IOP 1
   3. SUTURE IRRITATION 1
           In MST group , one patient developed graft dehiscence for which 
suturing  was done.  One patient developed infection and was treated 
with antibiotic eye ointment. One patient had suture irritation and suture 
was removed. One patient had suture site granuloma which was excised 
and regrafting was done after inflammation subsided. 
           In LCAT group, 3 patients had graft retraction, 2 were in position 
and  were  followed  up  and  one  needed  regrafting.  One  patient  had 
corneal  dellen  which  was  due  to  edematous  corneal  graft  and  was 
treated with topical tear substitutes. 2 patients had suture irritation and 
suture was removed. One patient had donor site granuloma which was 
excised and raw area covered with adjacent conjunctiva.
           In MMC group, one patient each had avascularity near limbus, 
suture  irritation  and  raised  IOP.  Suture  was  removed  and  steroids 
withdrawn for raised IOP and followed up.
DISCUSSION
                  Surgical excision is the principal mode of theraphy for 
pterygia.  But  the  high  incidence  of  recurrence  following  excisiom 
remains a challenge unmet and a problem unsolved. The evolution of 
various surgical techniques & various adjuncts to surgical excision has 
been based on the sole aim of preventing recurrence.
                 The various procedures used in the management of pterygia  
may be evaluated on the basis of two principal criteria namely, safety 
(freedom from sight threatening complications) and efficacy (freedom 
from recurrence). Also given the widespread distribution of pterygia in 
the  community,  the  procedure  should  be  feasible  enough  to  be 
performed under different clinical settings. 
                  The recurrence rates among various surgical procedures 
found  in  this  study  showed  12%  in  Limbal  Conjunctival  Autograft 
group,  16% in  Mitomycin  C group and 20% in  plain  Merest  Sclera 
technique group. The least recurrence rates were in LCAT group.
                  Merest sclera technique, which is a primary conjunctival 
closure shows higher recurrence rates, probably due to less number of 
limbal stem cells in the graft area. 
     A study by Prabhasawat et al. showed recurrence rates upto 45% 
with  primary  closure  of  conjunctiva  (Ophthalmology  1997;104;974-
985). Recurrence rates as low as 2.1%  with Merest  sclera have also 
been quoted in literature. Our study showed moderately high recurrence 
rate with this technique. The complications were graft dehiscence, graft 
infection & suture irritation which can be treated. 
                   The various adjunctive treatments include use of Mitomycin  
C both intraoperatively and postoperatively. There have been reports in 
literature with serious sight threatening complications with use of post 
operative Mitomycin C (Ophthalmology 1992;99;1647-54). 
          Intra operative use of MMC however has been associated with 
less  complications  and  low  recurrence  rates.  This  study  showed 
moderately higher rate of 16%. 
          Mitomycin C is an antimetabolite with radiomimetic properties. It  
causes suppression of development of collagen fibres in the process of 
wound healing. Thus it inhibits the formation of granulation tissue and 
regrowth  of  new  vessels  on  wound  surface.  This  can  be  used  in 
aggressive and large vascularised pterygia. 
          Frucht- Pery reported that using MMC intraoperatively for 5 mins 
in a concentration of 0.02% showed recurrence rates upto 5% (Cornea 
1994;13;411-13). But shorter time exposure is associated with decreased 
toxicity  and  more  efficacy.  Lam  et  al  showed  higher  incidence  of 
superficial melting with longer application time.
           Singh G et al. reported a recurrence rate of 1.7% with intra 
operative  use  of  MMC  in  a  concentration  of  0.4mg/ml  (Cornea 
1990;9;331-4). But higher rate of complications were associated with 
this concentration.
          Cheng HC et  al. reported a recurrence rate of 7.9% with intra 
operative use of MMC for 30 seconds in a concentration of 0.02% after 
a follow up of 27.3 months (Cornea 2001;20;1;24-9).
          Demorik A et  al.  reported a recurrence rate  of  5-9% with 
intraoperative use of MMC in concentrations of 0.02%  for 3 minutes 
with no significant complications (Eur J Ophthalmol 1998;8;3;153-6). 
But  Dougherty  et  al.  reported  one  case  of  corneoscleral  melt  with 
similar method in a series.
           The recurrence rate in this study correlates somewhat with the 
recurrence  rates  in  literature.  The  complication  of  avascularity  near 
limbus occurs later with no significant adverse effects. But the efficacy 
of MMC in this concentration needs long term follow up for occurrence 
of complications. 
            Frucht-Pery and Ilsar demonstrated that a lower concentration of  
MMC  administered  over  shorter  time  increases  safety  without 
compromising efficacy.
            Conjunctival autografting is widely accepted as a safe and 
effective surgical modality, in the treatment of pterygium but recurrence 
rates  still  vary  considerably  in  literature  upto  39%.   Recently  the 
importance  of  including limbal  conjunctiva in the autograft  has been 
emphasised to prevent recurrence.
          The Limbal Conjunctival Autograft group in this study is the 
procedure  associated  with  less  recurrence  rates(12%).  The  recent 
concept in pathogenesis of pterygium is localised damage to limbal cells 
brought  about  by  exposure  to  UV  rays  (DJO  1997;5;editorial).  The 
surgical  procedure while  removing the damaged cells  replenishes the 
area  with  healthy  limbal  stem cells  from superotemporal  conjunctiva 
which is less exposed to actinic damage. 
          The importance of  LCAT has been reported by Srinivas et al. 
(IJO 1998;46;4) . 
         Shimazaki et al  studied role of LCAT in primary pterygium for a 
follow up of 10.5 months and found recurrence rates of 7.4%
    Gris et al.  similarly gave no recurrence rates in a study group of 
recurrent pterygia (Ophthalmic Surg Lasers 1996;27;917-23) .
          Similarly many other studies show recurrence rates upto 9.2% 
over  a  follow  up  of  6-29  months  with  majority  occurring  within  6 
months.
           The rates in this study is significantly lower than other two 
groups. The post operative complications were minimal and could be 
managed by further simple procedures.  Most of them were related to 
surgical technique and can be avoided by marking the epithelial surface 
if graft with cautery or gentian violet. Retraction and shrinkage can be 
avoided  by  taking  as  thin  a  graft  as  possible  and  by  taking  a  graft 
slightly larger than bare scleral area.    
     With the above results, it is concluded that despite LCAT is a time 
consuming procedure, it is a safe and effective technique for different 
grades  of  pterygium  in  preventing  recurrence  rates  with  minimal 
complications.
SUMMARY
        In this study of 75 patients with pterygia, most patients (58%) were 
in age group of 30-50 years. 59% of the patients in this study group 
were women. 96% of patients had nasal pterygium. The mean size of 
pterygium operated was 2.66mm. The commonest indication for surgery 
was ocular irritation (38%) followed by cosmetic disfigurement (32%) 
followed by recurrent  inflammation & visual  impairment  (15%). The 
average follow up period was 6 months to 18 months and 90% of the 
patients  were followed for  18 months.  The recurrence rate  was  20% 
with Merest sclera technique, 16% with Mitomycin C group and 12% 
with  Limbal  Conjunctival  Autograft  group.  Most  of  the  recurrences 
(58%) were found during 6 weeks to 3 months after surgery. Most of the 
patients who developed recurrence were in the age group 40-60years. 
Graft  retraction  was  the  commonest  side  effect  following  LCAT.  2 
patients  showed suture irritation which was removed at  the end of 6 
weeks. Corneal dellen formation &granulation at donor site were other 
complications.  1 patient  developed raised IOP in MMC group which 
returned to normal after steroid withdrawal. Other complications were 
avascularity near limbus & suture irritation. Graft dehiscence, infection, 
suture irritation and suture site granuloma were associated with Merest 
sclera technique.  
CONCLUSION
                Limbal conjunctival autografting is a safe and effective  
procedure  in  the  management  of  pterygium.  The  recurrence  rate 
following limbal  conjunctival  autografting  is  significantly  lower  than 
that  following  primary  conjunctival  closure  and  adjunctive  use  of 
Mitomycin C.
                The advantages of Limbal Conjunctival Autografting over 
other modalities of treatment are
• Low recurrence rates
• Fewer and no sight threatening complications
• Offers anatomical and physiological restoration of ocular surface
• Simple  procedure  not  requiring  additional  surgical  skill  or 
instrumentation
• Cost effective
• Does not require any special post operative care.
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PROFORMA
CASE NO :
NAME : AGE : IP NO :
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RIGHT EYE : LEFT EYE :
TOTAL NO OF HOURS SPENT OUTDOORS IN DAYLIGHT
PERSONS USING UMBRELLA / CAP / CLOTH
SYMPTOMS OF
• OCULAR IRRITATION
• RECURRENT INFLAMMATION
• VISUAL IMPAIRMENT
• COSMETIC DISFIGUREMENT
TYPE OF PTERYGIUM
- PRIMARY
     
     -    RECURRENT
GRADE OF PTERYGIUM
• T1
• T2
• T3
LOCATION OF PTERYGIUM
- NASAL
- TEMPORAL
- DOUBLE HEAD
EXTENSION OF PTERYGIUM
 -   RE
      -   LE
SIZE IN MILLIMETER
- RE
- LE
LID CLOSURE
- COMPLETE
-    INCOMPLETE
ORBIT
- NORMAL
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SLIT LAMP EXAMINATION
   
     -     GRADING DONE ACCORDING TO THE RELATIVE 
TRANSLUCENCY OF BODY OF PTERYGIA.
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